UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...

Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...

After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...

The world’s most profitable hedge fund has started betting against shares in GSK (GSK), the first significant short on the FTSE 100 drugmaker’s stock for more than a decade, The Times’ Ben Martin ...

Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...

Citadel revealed it has taken a £305m short position against GSK. This rises in value as the share price falls. This is the biggest bet against this business since 2013. Under UK rules ...

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the compan... (Alliance News) - The hedge fund targeting ...

The FTSE 100 and European stocks were mixed at the open on Monday, as traders digest the potential of escalating tensions ...